Silencing of acetyl-CoA carboxylase-α (ACACA) inhibits the proliferation of LnCAP prostate cancer cells [44], and inhibition of SREBP2 processing was found to reduce the viability of prostate cancer cells, particularly in lipoprotein deficient serum [45]. The gene discussed is SREBF2; the disease is prostate carcinoma.